Industry praise for AI innovation bill comes amid consumer, FTC push for public benefits

Legislation to support public-private partnerships toward artificial intelligence innovation is spurring kudos from industry while a background debate brews about the use of “march-in” rights to lower drug prices and other efforts to ensure the public benefits from its investments to advance AI technology.

“Congress is proceeding in exactly the right way right now,” said Paul Lekas, senior vice president and head of global public policy and government affairs for the Software and Information Industry Association. “I think that we...